2025 annual financial data
Compass Therapeutics 2025 Operating cash flow
Direct answer
Operating cash flow was -49,143,000 USD.
Operating income was -72,839,000 USD and net income was -66,489,000 USD.
Operating cash flow was -49,143,000 USD.
Get free Compass Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -72,839,000 USD
- Net income
- -66,489,000 USD
- Operating cash flow
- -49,143,000 USD